Market Value802,715,000
Total Holdings59
File Date2019-02-22
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
GWP / GW Pharmaceuticals plc
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
PDSB / PDS Biotechnology Corporation
PCRX / Pacira BioSciences, Inc.
OMED / OptMed Inc
EPZM / Epizyme Inc
APLS / Apellis Pharmaceuticals, Inc.
ARQL / ArQule, Inc.
DCPH / Deciphera Pharmaceuticals, Inc.
FOMX / Foamix Pharmaceuticals Ltd.
ETTX / Entasis Therapeutics Holdings Inc
ICPT / Intercept Pharmaceuticals Inc
CNAT / Conatus Pharmaceuticals Inc.
XNCR / Xencor, Inc.
HRTX / Heron Therapeutics, Inc.
ITRM / Iterum Therapeutics plc
TSRO / TESARO, Inc.
CLVS / Clovis Oncology Inc
BOLD / Boundless Bio, Inc.
OSMT / Osmotica Pharmaceuticals Plc
RYTM / Rhythm Pharmaceuticals, Inc.
OCGN / Ocugen, Inc.
CPRX / Catalyst Pharmaceuticals, Inc.
BHVN / Biohaven Ltd.
OBSV / ObsEva SA.
FOLD / Amicus Therapeutics, Inc.
ONCE / Spark Therapeutics, Inc.
KDMN / Kadmon Holdings Inc
KURA / Kura Oncology, Inc.
ACRS / Aclaris Therapeutics, Inc.
MOLN / Molecular Partners AG
ESPR / Esperion Therapeutics, Inc.
H03579101 / Auris Medical Holding Ltd
ADMS / Adamas Pharmaceuticals Inc
MOR / MorphoSys AG - Depositary Receipt (Common Stock)
FSTX / F-star Therapeutics Inc
PBYI / Puma Biotechnology, Inc.
US74257L1089 / Principia Biopharma Inc.
US16706W1027 / Chiasma Inc
0HBB / Aimmune Therapeutics Inc
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
14161H108 / Cardtronics PLC
DERM / Journey Medical Corporation
CLSD / Clearside Biomedical, Inc.
US33830X1046 / Five Prime Therapeutics Inc
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
MRUS / Merus N.V.
OTIC / Otonomy Inc
FATE / Fate Therapeutics, Inc.
US0153511094 / Alexion Pharmaceuticals, Inc.
018490100 / Allergan plc
NBIX / Neurocrine Biosciences, Inc.
BPMC / Blueprint Medicines Corporation
INCY / Incyte Corporation
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
SNY / Sanofi - Depositary Receipt (Common Stock)
MGNX / MacroGenics, Inc.
CHRS / Coherus Oncology, Inc.
KALA / KALA BIO, Inc.
BMRN / BioMarin Pharmaceutical Inc.
GILD / Gilead Sciences, Inc.
KDNY / Chinook Therapeutics Inc
EXEL / Exelixis, Inc.
KNSA / Kiniksa Pharmaceuticals, Ltd.
RETA / Reata Pharmaceuticals Inc - Class A
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock) Call
RIGL / Rigel Pharmaceuticals, Inc.
YMAB / Y-mAbs Therapeutics, Inc.
IMGN / ImmunoGen, Inc.
NCNA / NuCana plc - Depositary Receipt (Common Stock)
SVRA / Savara Inc.
ANAB / AnaptysBio, Inc.
NTRA / Natera, Inc.
SRPT / Sarepta Therapeutics, Inc.
SYBX / Synlogic, Inc.
FGEN / FibroGen, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)